AQP4 and Alzheimer disease: Despite the fact that GFAP and thus astrogliosis can be considered a robust indicator of the disease, we failed to observe any significant overt change in the water channel AQP4, thought to be involved in the glymphatic clearance of Aβ [82, 83] and proposed to be disrupted in AD [36].